Genome-wide DNA methylation analysis in melanoma reveals the importance of CpG methylation in MITF regulation

Journal of Investigative Dermatology

Volumn 135, Issue 7, 2015, Pages 1820-1828

  Lauss, Martin ^a   Haq, Rizwan ^b   Cirenajwis, Helena ^a   Phung, Bengt ^a   Harbst, Katja ^a   Staaf, Johan ^a   Rosengren, Frida ^a   Holm, Karolina ^a   Aine, Mattias ^a   Jirström, Karin ^a,c   Borg, Ake ^a   Busch, Christian ^d   Geisler, Jürgen ^e,f   Lønning, Per E ^d   Ringnér, Markus ^a   Howlin, Jillian ^a   Fisher, David E ^b   Jönsson, Göran ^a  

^a LUND UNIVERSITY   (Sweden)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF BERGEN   (Norway)

^e AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; CXXC1 PROTEIN, HUMAN; DNA BINDING PROTEIN;

ARTICLE; CANCER STAGING; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; FIBROBLAST; GENE CONTROL; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; KERATINOCYTE; MELANOCYTE; MELANOMA; MELANOMA CELL LINE; MICROARRAY ANALYSIS; PIGMENTATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; COMPARATIVE STUDY; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; IMMUNOHISTOCHEMISTRY; NONPARAMETRIC TEST; PATHOLOGY; SKIN TUMOR; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; DNA METHYLATION; DNA-BINDING PROTEINS; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME-WIDE ASSOCIATION STUDY; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MELANOCYTES; MELANOMA; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; NEOPLASM STAGING; SKIN NEOPLASMS; STATISTICS, NONPARAMETRIC;

EID: 84931572348     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2015.61     Document Type: Article

References (43)

1. Bonazzi VF, Nancarrow DJ, Stark MS, et al. (2011) Cross-platform array screening identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as genes frequently silenced by methylation in melanoma. PLoS One 6:e26121
2. Chapman PB, Hauschild A, Robert C, et al. (2011) Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 364: 2507-16
3. Cheli Y, Ohanna M, Ballotti R, et al. (2010) Fifteen-year quest for microphthalmia-Associated transcription factor target genes. Pigment Cell Melanoma Res 23:27-40
4. Conway K, Edmiston SN, Khondker ZS, et al. (2011) DNA-methylation profiling distinguishes malignant melanomas from benign nevi. Pigment Cell Melanoma Res 24:352-60
5. Dahl C, Abildgaard C, Riber-Hansen R, et al. (2014) KIT is a frequent target for epigenetic silencing in cutaneous melanoma. J Invest Dermatol 135: 516-24
6. Davies H, Bignell GR, Cox C, et al. (2002) Mutations of the BRAF gene in human cancer. Nature 417:949-54
7. Du J, Miller AJ, Widlund HR, et al. (2003) MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma. Am J Pathol 163:333-43
8. Easwaran H, Johnstone SE, Van Neste L, et al. (2012) A DNA hypermethylation module for the stem/progenitor cell signature of cancer. Genome Res 22: 837-49
9. Ecsedi S, Hernandez-Vargas H, Lima SC, et al. (2014) DNA methylation characteristics of primary melanomas with distinct biological behaviour. PLoS One 9:e96612
10. Furuta J, Nobeyama Y, Umebayashi Y, et al. (2006) Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas. Cancer Res 66:6080-6
11. Gao L, Smit MA, van den Oord JJ, et al. (2013) Genome-wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma. Pigment Cell Melanoma Res 26:542-54
12. Gao L, van den Hurk K, Moerkerk PT, et al. (2014) Promoter CpG island hypermethylation in dysplastic nevus and melanoma: CLDN11 as an epigenetic biomarker for malignancy. J Invest Dermatol 134: 2957-66
13. Garraway LA, Widlund HR, Rubin MA, et al. (2005) Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436:117-22
14. Haq R, Shoag J, Andreu-Perez P, et al. (2013) Oncogenic BRAF regulates oxidative metabolism via PGC1alpha and MITF. Cancer Cell 23:302-15
15. Harbst K, Staaf J, Lauss M, et al. (2012) Molecular profiling reveals low-And high-grade forms of primary melanoma. Clin Cancer Res 18:4026-36
16. Hodis E, Watson IR, Kryukov GV, et al. (2012) A landscape of driver mutations in melanoma. Cell 150:251-63
17. Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57
18. Jonsson G, Busch C, Knappskog S, et al. (2010) Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome. Clin Cancer Res 16:3356-67
19. Jonsson G, Dahl C, Staaf JS, et al. (2007) Genomic profiling of malignant melanoma using tiling-resolution arrayCGH. Oncogene 26:4738-48
20. Koga Y, Pelizzola M, Cheng E, et al. (2009) Genome-wide screen of promoter methylation identifies novel markers in melanoma. Genome Res 19: 1462-70
21. Konieczkowski DJ, Johannessen CM, Abudayyeh O, et al. (2014) A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors. Cancer Discov 4:816-27
22. Krauthammer M, Kong Y, Ha BH, et al. (2012) Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet 44:1006-14
23. Landan G, Cohen NM, Mukamel Z, et al. (2012) Epigenetic polymorphism and the stochastic formation of differentially methylated regions in normal and cancerous tissues. Nat Genet 44:1207-14
24. Lauss M, Aine M, Sjodahl G, et al. (2012) DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation status. Epigenetics 7:858-67
25. Lee TI, Jenner RG, Boyer LA, et al. (2006) Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125:301-13
26. Li JL, Mazar J, Zhong C, et al. (2013) Genome-wide methylated CpG island profiles of melanoma cells reveal a melanoma coregulation network. Sci Rep 3:2962
27. Lian CG, Xu Y, Ceol C, et al. (2012) Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 150:1135-46
28. Mansky KC, Sankar U, Han J, et al. (2002) Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NFkappa B ligand signaling. J Biol Chem 277:11077-83
29. Marzese DM, Scolyer RA, Huynh JL, et al. (2013) Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis. Hum Mol Genet 23:226-38
30. Marzese DM, Scolyer RA, Roque M, et al. (2014) DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations. Neuro Oncol 16:1499-509
31. Miller AJ, Levy C, Davis IJ, et al. (2005) Sumoylation of MITF and its related family members TFE3 and TFEB. J Biol Chem 280:146-55
32. Murakami H, Arnheiter H (2005) Sumoylation modulates transcriptional activity of MITF in a promoter-specific manner. Pigment Cell Res 18: 265-77
33. Noushmehr H, Weisenberger DJ, Diefes K, et al. (2010) Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17:510-22
34. Sharma SV, Lee DY, Li B, et al. (2010) A chromatin-mediated reversible drugtolerant state in cancer cell subpopulations. Cell 141:69-80
35. Sigalotti L, Covre A, Fratta E, et al. (2012) Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients. J Transl Med 10:185
36. Steingrimsson E, Copeland NG, Jenkins NA (2004) Melanocytes and the microphthalmia transcription factor network. Annu Rev Genet 38: 365-411
37. Tanemura A, Terando AM, Sim MS, et al. (2009) CpG island methylator phenotype predicts progression of malignant melanoma. Clin Cancer Res 15:1801-7
38. Thomas NE, Slater NA, Edmiston SN, et al. (2014) DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features. Pigment Cell Melanoma Res 27:1097-105
39. van den Hurk K, Niessen HE, Veeck J, et al. (2012) Genetics and epigenetics of cutaneous malignant melanoma: a concert out of tune. Biochim Biophys Acta 1826:89-102
40. Vashisht Gopal YN, Rizos H, Chen G, et al. (2014) Inhibition of mTORC1/2 overcomes resistance to MAPK pathway inhibitors mediated by PGC1alpha and Oxidative Phosphorylation in melanoma. Cancer Res 74: 7037-47
41. Weisenberger DJ, Siegmund KD, CampanM, et al. (2006) CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38: 787-93
42. Wu M, Hemesath TJ, Takemoto CM, et al. (2000) c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev 14:301-12
43. Yokoyama S, Woods SL, Boyle GM, et al. (2011) A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature 480: 99-103